News | November 07, 2023
Sun Pharma Advanced Research posts Q2 FY24 loss at Rs. 86.42 Cr
Sun Pharma Advanced Research Company Limited has reported total income of Rs. 29.67 crores during the period ended September 30, 2023
Sun Pharma Advanced Research Company Limited has reported total income of Rs. 29.67 crores during the period ended September 30, 2023
Divi's Laboratories Limited has reported total income of Rs. 1995 crores during the period ended September 30, 2023
Gland Pharma has reported total income of Rs. 1426.57 crores during the period ended September 30, 2023
Max Healthcare Institute has reported total income of Rs. 1408.64 crores during the period ended September 30, 2023
Zydus Wellness has reported total income of Rs. 444 crores during the period ended September 30, 2023
Metropolis Healthcare has reported total income of Rs. 309.71 crores during the period ended September 30, 2023
Orchid Pharma reported total income of Rs. 207.11 crores during the period ended September 30, 2023
Poly Medicure has reported total income of Rs. 351.38 crores during the period ended September 30, 2023
The agreement demonstrates a shared commitment to advance precision medicine and improve patient outcomes in the region
This product will be manufactured at Lupin's Nagpur facility in India
Subscribe To Our Newsletter & Stay Updated
